Easy Access and Express Report Delivery Service
Highlights The global Medical Radioisotopes market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029. North American market for Medical Radioisotopes is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Asia-Pacific market for Medical Radioisotopes is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. The major global companies of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue. The global market for Medical Radioisotopes in Nuclear Therapy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Tc-99m, which accounted for % of the global market of Medical Radioisotopes in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Medical Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Radioisotopes. The Medical Radioisotopes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Radioisotopes market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Medical Radioisotopes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Medical Radioisotopes by Type 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) 1.2.2 Tc-99m 1.2.3 Cobalt-60 1.2.4 Iodine Radioisotopes 2.3 Medical Radioisotopes by Application 2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) 2.3.2 Nuclear Therapy 2.3.3 Equipment Radioactive Source 2.3.4 Diagnosis 2.3.5 Others 2.4 Assumptions and Limitations 3 Medical Radioisotopes Breakdown Data by Type 3.1 Global Medical Radioisotopes Historic Market Size by Type (2018-2023) 3.2 Global Medical Radioisotopes Forecasted Market Size by Type (2023-2028) 4 Medical Radioisotopes Breakdown Data by Application 4.1 Global Medical Radioisotopes Historic Market Size by Application (2018-2023) 4.2 Global Medical Radioisotopes Forecasted Market Size by Application (2018-2023) 5 Global Growth Trends 5.1 Global Medical Radioisotopes Market Perspective (2018-2029) 5.2 Global Medical Radioisotopes Growth Trends by Region 5.2.1 Global Medical Radioisotopes Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Medical Radioisotopes Historic Market Size by Region (2018-2023) 5.2.3 Medical Radioisotopes Forecasted Market Size by Region (2024-2029) 5.3 Medical Radioisotopes Market Dynamics 5.3.1 Medical Radioisotopes Industry Trends 5.3.2 Medical Radioisotopes Market Drivers 5.3.3 Medical Radioisotopes Market Challenges 5.3.4 Medical Radioisotopes Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Medical Radioisotopes Players by Revenue 6.1.1 Global Top Medical Radioisotopes Players by Revenue (2018-2023) 6.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2018-2023) 6.2 Global Medical Radioisotopes Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Medical Radioisotopes Head office and Area Served 6.4 Global Medical Radioisotopes Players, Product Type & Application 6.5 Global Medical Radioisotopes Players, Date of Enter into This Industry 6.6 Global Medical Radioisotopes Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Medical Radioisotopes Market Size (2018-2029) 7.2 North America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Medical Radioisotopes Market Size by Country (2018-2023) 7.4 North America Medical Radioisotopes Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Medical Radioisotopes Market Size (2018-2029) 8.2 Europe Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Medical Radioisotopes Market Size by Country (2018-2023) 8.4 Europe Medical Radioisotopes Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Medical Radioisotopes Market Size (2018-2029) 9.2 Asia-Pacific Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Medical Radioisotopes Market Size by Country (2018-2023) 9.4 Asia-Pacific Medical Radioisotopes Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Medical Radioisotopes Market Size (2018-2029) 10.2 Latin America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Medical Radioisotopes Market Size by Country (2018-2023) 10.4 Latin America Medical Radioisotopes Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Medical Radioisotopes Market Size (2018-2029) 11.2 Middle East & Africa Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Medical Radioisotopes Market Size by Country (2018-2023) 11.4 Middle East & Africa Medical Radioisotopes Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 NRG 11.1.1 NRG Company Detail 11.1.2 NRG Business Overview 11.1.3 NRG Medical Radioisotopes Introduction 11.1.4 NRG Revenue in Medical Radioisotopes Business (2017-2022) 11.1.5 NRG Recent Development 11.2 IRE 11.2.1 IRE Company Detail 11.2.2 IRE Business Overview 11.2.3 IRE Medical Radioisotopes Introduction 11.2.4 IRE Revenue in Medical Radioisotopes Business (2017-2022) 11.2.5 IRE Recent Development 11.3 ANSTO 11.3.1 ANSTO Company Detail 11.3.2 ANSTO Business Overview 11.3.3 ANSTO Medical Radioisotopes Introduction 11.3.4 ANSTO Revenue in Medical Radioisotopes Business (2017-2022) 11.3.5 ANSTO Recent Development 11.4 NTP Radioisotopes 11.4.1 NTP Radioisotopes Company Detail 11.4.2 NTP Radioisotopes Business Overview 11.4.3 NTP Radioisotopes Medical Radioisotopes Introduction 11.4.4 NTP Radioisotopes Revenue in Medical Radioisotopes Business (2017-2022) 11.4.5 NTP Radioisotopes Recent Development 11.5 China National Nuclear Corporation 11.5.1 China National Nuclear Corporation Company Detail 11.5.2 China National Nuclear Corporation Business Overview 11.5.3 China National Nuclear Corporation Medical Radioisotopes Introduction 11.5.4 China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2017-2022) 11.5.5 China National Nuclear Corporation Recent Development 11.6 Rosatom 11.6.1 Rosatom Company Detail 11.6.2 Rosatom Business Overview 11.6.3 Rosatom Medical Radioisotopes Introduction 11.6.4 Rosatom Revenue in Medical Radioisotopes Business (2017-2022) 11.6.5 Rosatom Recent Development 11.7 Nordion 11.7.1 Nordion Company Detail 11.7.2 Nordion Business Overview 11.7.3 Nordion Medical Radioisotopes Introduction 11.7.4 Nordion Revenue in Medical Radioisotopes Business (2017-2022) 11.7.5 Nordion Recent Development 11.8 Eckert & Ziegler Strahlen 11.8.1 Eckert & Ziegler Strahlen Company Detail 11.8.2 Eckert & Ziegler Strahlen Business Overview 11.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Introduction 11.8.4 Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2017-2022) 11.8.5 Eckert & Ziegler Strahlen Recent Development 11.9 Polatom 11.9.1 Polatom Company Detail 11.9.2 Polatom Business Overview 11.9.3 Polatom Medical Radioisotopes Introduction 11.9.4 Polatom Revenue in Medical Radioisotopes Business (2017-2022) 11.9.5 Polatom Recent Development 13 Report Conclusion 14 Disclaimer